A. Gerber

发表

Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.

W. Craig, A. Vastola, A. Gerber, 1982, The Journal of infectious diseases.

Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitro.

A. Gerber, P. Wiprächtiger, U. Stettler-Spichiger, 1982, The Journal of infectious diseases.

Effects of an acute bacterial infection on serum thyroid hormones and nuclear triiodothyronine receptors in mice.

A. Gerber, U. Burgi, C. Feller, 1986, Endocrinology.

Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model

U. Flückiger, A. Gerber, C. Segessenmann, 1991, Antimicrobial Agents and Chemotherapy.

Postantibiotic suppression of bacterial growth.

W. Craig, D. Cohn, R. Bundtzen, 1981, Reviews of infectious diseases.

Once-daily versus thrice-daily administration of netilmicin in combination therapy ofPseudomonas aeruginosa infection in a man-adapted neutropenic animal model

U. Flückiger, S. Kozak, A. Gerber, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Use of Antimicrobials in Swiss Hospitals

J. Garbino, D. Lew, A. Gerber, 2012, Drugs.

Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.

A. Gerber, C. Segessenmann, B. Kuenzi, 1987, The Journal of antimicrobial chemotherapy.

Influence of Urinary pH on the Pharmacokinetics of Cinoxacin in Humans and on Antibacterial Activity In Vitro

P. Welling, W. Craig, R. Barbhaiya, 1982, Antimicrobial Agents and Chemotherapy.

Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics.

A. Gerber, C. Feller, B. Stalder, 1986, The Journal of infectious diseases.

Growth kinetics of respiratory pathogens after short exposures to ampicillin and erythromycin in vitro.

W. Craig, A. Gerber, 1981, The Journal of antimicrobial chemotherapy.

Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice.

W. Craig, W A Craig, A U Gerber, 1983, The Journal of infectious diseases.

Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.

W. Craig, A. Gerber, 1982, The Journal of laboratory and clinical medicine.

Postantibiotic effect: an update and an outlook on clinical relevance

A. Gerber, 1993 .

The impact of the pre-treatment interval on antimicrobial efficacy in a biological model.

S. Kozak, A. Gerber, C. Segessenmann, 1993, The Journal of antimicrobial chemotherapy.

In-vivo assessment of in-vitro killing patterns of Pseudomonas aeruginosa.

A. Gerber, C. Feller-Segessenmann, 1985, The Journal of antimicrobial chemotherapy.

[What does the minimal inhibitory concentration of an antibiotic hide from the clinician? Experimental examples].

W. Craig, A. Gerber, C. Feller-Segessenmann, 1983, Schweizerische medizinische Wochenschrift.

Pharmacokinetics of Cefoperazone: A Review

W. Craig, A. Gerber, 2012, Drugs.

Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.

W. Craig, R. Greenfield, A. Gerber, 1983, Reviews of infectious diseases.

Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.

A. Gerber, 1990, Scandinavian journal of infectious diseases. Supplementum.

Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland.

P. Vernazza, J. Unger, J. Garbino, 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Worldwide experience with bacampicillin administered twice a day.

W. Craig, A. Gerber, 1981, Reviews of infectious diseases.

[Navigating in evidence-poor waters - how much hydration is needed at the end of life? The recommendations of a Swiss expert group (Bigorio group)].

A. Gerber, 2012, Therapeutische Umschau. Revue thérapeutique.

Simulation of human pharmacokinetic profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia model.

A. Gerber, C. Segessenmann, B. Stalder, 1990, Scandinavian Journal of Infectious Diseases. Supplementum.